Skip Navigation
Skip to contents

Res Vestib Sci : Research in Vestibular Science

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > Res Vestib Sci > Volume 11(4); 2012 > Article
Clinical Trial Treatment of Vestibular Migraine
Byung Kun Kim

DOI: https://doi.org/
Department of Neurology, Eulji General Hospital, Eulji University College of Medicine, Seoul, Korea. kbk1403@eulji.ac.kr
  • 1,870 Views
  • 40 Download
  • 0 Crossref
  • 0 Scopus

Although vestibular migraine is considered to be the most common cause of non-positional recurrent vertigo, well designed clinical trials for the treatment of vestibular migraine are not yet available. Management includes dietary and lifestyle modifications and medications. Since treatment for vestibular migraine generally follows the recommended treatment of migraine, most drugs are also used for the prevention of migraine. In this review, preventive treatment with beta blockers, calcium channel blockers, antiepileptic drugs, antidepressants, acetazolamide and triptans are described. Nonpharmacological management such as diet, sleep and avoidance of triggers are also recommended for vestibular migraine.


Res Vestib Sci : Research in Vestibular Science